Actions

CD56: Revision history

View logs for this page (view abuse log)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 June 2023

  • curprev 13:2013:20, 8 June 2023‎ John talk contribs‎ 954 bytes +5‎ No edit summary
  • curprev 13:2013:20, 8 June 2023‎ John talk contribs‎ 949 bytes +949‎ Created page with " <div style="background-color: #E0EEEE; {{round corners}} padding: 2em 2em; margin-right: 5px;"> :<span style="color:navy">'''Summary'''</span> :CD56 principally is used in the identification and classification of LGL disorders; CD56 is also expressed in some cases of myeloma and may be used in detection of MRD. </div> :<span style="color:navy">'''Background'''</span> CD56 (Neural Cell Adhesion Molecule or NCAM) as most expressed on natural killer cells, but has..."
Retrieved from ‘https://haematologyetc.co.uk/index.php?title=CD56’